Pharming Group NV - Company Profile
Powered by 
All the data and insights you need on Pharming Group NV in one report.
$295
- Save hours of research time and resources with
our up-to-date Pharming Group NV Strategy Report
- Understand Pharming Group NV position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Pharming Group NV Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Pharming Group NV Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 08 Feb 2022 | Lorem |
| Pharming’s prophylactic HAE strategy considers different routes of admin, dosing after FDA CRL, sources say; experts see BioCryst’s Phase II/III BCX7353 as competitive threat | 18 Jan 2019 | Jennifer C. Smith-Parker |
| Pharming seeks Latin American partner by YE14 to file and commercialise HAE drug Ruconest - CEO | 23 Apr 2014 | Jinan Harb |
| Santarus/Pharming’s Ruconest for hereditary angioedema likely to be FDA-approved but market traction minimal | 25 Jul 2012 | Jennifer C. Smith-Parker |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer